Pursuant to Regulation 30 of the SEBI (listing Obligation and Disclosure Requirement) Regulations, 2015, iStreet Network has informed that the company has received listing approval for 10,83,334 equity shares vide letter LOD/PREF/AP/FIP/591/2026-27 dated July 31, 2026 from BSE issued to non-promoter on preferential basis pursuant to conversion of warrants. The company has enclosed a copy of the Listing Approval of the BSE.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1935.00 |
| Dr. Reddys Labs. | 1198.95 |
| Cipla | 1461.55 |
| Lupin | 2264.70 |
| Zydus Lifesciences | 1204.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: